Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients
APDT-T2D
Regular Use of Antibacterial Photodynamic Therapy in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients - Special Attention to Diabetic Balance and Metabolism
1 other identifier
interventional
150
1 country
1
Brief Summary
This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Jan 2025
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedStudy Start
First participant enrolled
January 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
August 6, 2025
August 1, 2025
2.9 years
June 26, 2024
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bleeding on probing (BOP)
Change in bleeding on probing (BOP) A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual) Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent" BOP is reported as the percentage (%) of sites with positive findings Calculation formula: number of bleeding sites/ 6 times number of teeth
12 months
Secondary Outcomes (13)
Visual Plaque Index (VPI)
6 months
Visual Plaque Index (VPI)
12 months
Periodontal Pocket Depth (PPD)
6 months
Periodontal Pocket Depth (PPD)
12 months
Clinical Attachment Level (CAL)
6 months
- +8 more secondary outcomes
Study Arms (2)
Study group
EXPERIMENTALStandard oral hygiene and home-use of Lumoral Treatment aPDT device.
Control group
ACTIVE COMPARATORStandard oral hygiene
Interventions
Photodynamic antibacterial dual-light device home-use with a marker substance
Eligibility Criteria
You may qualify if:
- Diabetic patient treated at community health care;
- At least 18 years old;
- Presence of ≥20 teeth;
- Agreement to participate in the study, and to sign a written consent form;
- Ability to cooperate with the treatment protocol according to coordinator investigator's assessment.
You may not qualify if:
- Oral thrush;
- Known sensitivity to near-infrared or antibacterial blue light.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wellbeing Services County of Pirkanmaalead
- Tampere Universitycollaborator
- University of Helsinkicollaborator
- Mehiläinen Health Care Servicescollaborator
Study Sites (1)
Wellbeing Services of County Pirkanmaa
Tampere, Pirkanmaa, 33520, Finland
Related Publications (8)
Ahmad R, Haque M. Oral Health Messiers: Diabetes Mellitus Relevance. Diabetes Metab Syndr Obes. 2021 Jul 1;14:3001-3015. doi: 10.2147/DMSO.S318972. eCollection 2021.
PMID: 34234496BACKGROUNDChoi SE, Sima C, Pandya A. Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes. Diabetes Care. 2020 Mar;43(3):563-571. doi: 10.2337/dc19-1201. Epub 2019 Dec 27.
PMID: 31882408BACKGROUNDGasner NS, Schure RS. Periodontal Disease. 2025 May 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554590/
PMID: 32119477BACKGROUNDKononen E, Gursoy M, Gursoy UK. Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med. 2019 Jul 31;8(8):1135. doi: 10.3390/jcm8081135.
PMID: 31370168BACKGROUNDNazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):72-80.
PMID: 28539867BACKGROUNDLiccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, Rengo G. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019 Mar 20;20(6):1414. doi: 10.3390/ijms20061414.
PMID: 30897827BACKGROUNDPakarinen S, Saarela RKT, Valimaa H, Heikkinen AM, Kankuri E, Noponen M, Alapulli H, Tervahartiala T, Raisanen IT, Sorsa T, Patila T. Home-Applied Dual-Light Photodynamic Therapy in the Treatment of Stable Chronic Periodontitis (HOPE-CP)-Three-Month Interim Results. Dent J (Basel). 2022 Nov 2;10(11):206. doi: 10.3390/dj10110206.
PMID: 36354651BACKGROUNDSalminen A, Maatta AM, Mantyla P, Leskela J, Pietiainen M, Buhlin K, Suominen AL, Paju S, Sattler W, Sinisalo J, Pussinen PJ. Systemic Metabolic Signatures of Oral Diseases. J Dent Res. 2024 Jan;103(1):13-21. doi: 10.1177/00220345231203562. Epub 2023 Nov 15.
PMID: 37968796BACKGROUND
Related Links
- Bashir, N.Z., Singh, HA. \& Virdee, S.S. Indocyanine green-mediated antimicrobial photodynamic therapy as an adjunct to periodontal therapy: a systematic review and meta-analysis. Clin Oral Invest 25, 5699-5710 (2021).
- Berger, V., Bour, L., Carter, K. et al. A roadmap to using randomization in clinical trials. BMC Med Res Methodol 21, 168 (2021).
- Borgnakke, W.S., Poudel, P. Front. Dent. Med, Volume 2 - 2021. Diabetes and Oral Health: Summary of Current Scientific Evidence for Why Transdisciplinary Collaboration Is Needed.
- Centers for Disease Control and Prevention (CDC), July 2023. Periodontal Disease.
- Sorsa, T, Nwhator, SO, Sakellari, D, Grigoriadis, A, Umeizudike, KA, Brandt, E, Keskin, M, Tervahartiala, T, Pärnänen, P, Gupta, S, Mohindra, R, Bostanci, N, Buduneli, N, Räisänen, IT. Front. Oral Health, 10 June 2022, Sec. Oral Infections and Microbes
- World Health Organization (WHO). Diabetes, Oct 2023. Newsroom, Fact sheets, Detail, Diabetes.
- Zhang Y., Leveille S.G., Shi L., Camhi S.M. Disparities in Preventive Oral Health Care and Periodontal Health Among Adults With Diabetes. Prev Chronic Dis 2021;18:200594
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Maria Heikkinen, Professor
Wellbeing Services of County Pirkanmaa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data will be collected using individual study codes for participants. Study codes do not reveal which group the participant has belonged to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 3, 2024
Study Start
January 23, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
August 6, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share